Afatinib With CT and RT for EGFR-Mutant NSCLC

NCT01553942 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Afatinib
RADIATION: Radiation
DRUG: Cisplatin
DRUG: Pemetrexed
PROCEDURE: Surgery

Sponsor

Massachusetts General Hospital